Invesco’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.39M Buy
382,210
+121,607
+47% +$443K ﹤0.01% 2723
2025
Q1
$500K Buy
260,603
+139,957
+116% +$269K ﹤0.01% 3137
2024
Q4
$229K Buy
120,646
+872
+0.7% +$1.66K ﹤0.01% 3476
2024
Q3
$158K Sell
119,774
-10,012
-8% -$13.2K ﹤0.01% 3544
2024
Q2
$132K Buy
129,786
+103,951
+402% +$106K ﹤0.01% 3700
2024
Q1
$47.3K Sell
25,835
-3,336
-11% -$6.11K ﹤0.01% 3792
2023
Q4
$36.2K Buy
29,171
+5,353
+22% +$6.64K ﹤0.01% 3769
2023
Q3
$27.2K Sell
23,818
-8,174
-26% -$9.32K ﹤0.01% 3827
2023
Q2
$29.3K Buy
+31,992
New +$29.3K ﹤0.01% 3834
2023
Q1
Sell
-245,507
Closed -$142K 3845
2022
Q4
$142K Sell
245,507
-5,017
-2% -$2.9K ﹤0.01% 3749
2022
Q3
$79K Sell
250,524
-14,026
-5% -$4.42K ﹤0.01% 3845
2022
Q2
$93K Sell
264,550
-15,408
-6% -$5.42K ﹤0.01% 3871
2022
Q1
$201K Buy
279,958
+89,594
+47% +$64.3K ﹤0.01% 3735
2021
Q4
$431K Sell
190,364
-12,021
-6% -$27.2K ﹤0.01% 3416
2021
Q3
$583K Buy
202,385
+15,163
+8% +$43.7K ﹤0.01% 3329
2021
Q2
$710K Buy
187,222
+26,111
+16% +$99K ﹤0.01% 3246
2021
Q1
$546K Buy
161,111
+131,414
+443% +$445K ﹤0.01% 3289
2020
Q4
$83K Sell
29,697
-576,649
-95% -$1.61M ﹤0.01% 3627
2020
Q3
$1.52M Sell
606,346
-486,094
-44% -$1.22M ﹤0.01% 2606
2020
Q2
$14.8M Sell
1,092,440
-42,816
-4% -$581K 0.01% 1417
2020
Q1
$8.61M Buy
+1,135,256
New +$8.61M ﹤0.01% 1598
2019
Q2
Sell
-1,141,290
Closed -$9.35M 3665
2019
Q1
$9.35M Buy
+1,141,290
New +$9.35M ﹤0.01% 1613
2018
Q2
Sell
-32,152
Closed -$306K 3837
2018
Q1
$306K Sell
32,152
-165,021
-84% -$1.57M ﹤0.01% 3487
2017
Q4
$2.93M Sell
197,173
-390,759
-66% -$5.81M ﹤0.01% 2318
2017
Q3
$11.6M Buy
587,932
+467,354
+388% +$9.19M ﹤0.01% 1480
2017
Q2
$1.73M Buy
+120,578
New +$1.73M ﹤0.01% 2667
2016
Q2
Sell
-68,611
Closed -$618K 3651
2016
Q1
$618K Buy
+68,611
New +$618K ﹤0.01% 3153
2015
Q3
Sell
-569
Closed -$6K 3757
2015
Q2
$6K Buy
+569
New +$6K ﹤0.01% 4103